UNKNOWN_PUMP
Report
- Report Number
- 3007566237-2014-01158
- Event Type
- Injury
- Date Received
- April 25, 2014
- Report Date
- April 11, 2014
- Manufacturer
- MEDTRONIC NEUROMODULATION
- Product Code
- LKK
- PMA / PMN Number
- P860004
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MD, US
- Reporter Occupation
- PHYSICIAN
Narratives
CONCOMITANT MEDICAL PRODUCTS: PRODUCT ID NEU_UNKNOWN_CATH, LOT# UNKNOWN, PRODUCT TYPE: CATHETER. (B)(4).
GHOSH, D., MAINALI, G., KHERA, J., LUCIANO, M. COMPLICATIONS OF INTRATHECAL BACLOFEN PUMPS IN CHILDREN: EXPERIENCE FROM A TERTIARY CARE CENTER. PEDIATRIC NEUROSURGERY. 2014. SUMMARY: INTRATHECAL BACLOFEN (ITB) THERAPY IS USEFUL IN TREATING SPASTICITY AND DYSTONIA BUT IT HAS MANY COMPLICATIONS, MORE SO IN CHILDREN. THE MAIN AIM OF THE STUDY WAS TO LOOK AT THE COMPLICATIONS OF ITB PUMPS IN CHILDREN WITH THE GOAL OF FUTURE PREVENTION. CHARTS OF ALL PATIENTS= 21 YEARS WITH AN ITB PUMP, IMPLANTED BY A SINGLE PEDIATRIC NEUROSURGEON, AT A SINGLE CENTER, BETWEEN 1996 AND 2011 WERE REVIEWED RETROSPECTIVELY. DATA REGARDING AN ITB TEST TRIAL WERE ALSO RECORDED. DURING 1996¿2011, 119 CHILDREN (MEAN AGE 13.2 YEARS) UNDERWENT ITB PUMP PLACEMENT; 84% HAD SPASTIC QUADRIPLEGIC CEREBRAL PALSY. THE GROSS MOTOR FUNCTION CLASSIFICATION SYSTEM LEVEL WAS =4 FOR MOST. THE PUMP WAS REMOVED IN 5 (4.2%) PATIENTS DUE TO INEFFICACY. THE MEAN FOLLOW-UP WAS 38 MONTHS. MECHANICAL COMPLICATIONS REQUIRING PUMP AND/OR CATHETER REVISION OCCURRED IN 19.3% AND INFECTIONS IN AN ADDITIONAL 21.8%. SEVEN PATIENTS (6%) HAD MENINGITIS. NO COMPLICATION WAS NOTED AFTER 72 MONTHS OF INITIAL PUMP INSERTION, EVEN AFTER PUMP REINSERTION. THERE IS A NEED FOR BETTER INFECTION CONTROL AS WELL AS BETTER PUMP, CATHETER AND SURGICAL TECHNOLOGY TO LOWER THE COMPLICATIONS OF ITB PUMPS IN CHILDREN. REPORTED EVENT: A 6 YEAR-OLD MALE WITH SPASTIC QUADRIPLEGIA AND A VENTRICULOPERITONEAL SHUNT DEVELOPED MENINGITIS WITHOUT INFECTION AT THE INCISION SITE. THE PUMP HAD BEEN PLACED IN 2001 WITH THE CATHETER TIP AT T10-T11. THE MENINGITIS DEVELOPED 2 WEEKS AFTER IMPLANT. (B)(6) WAS CULTURED AND IV ANTIBIOTICS WERE ADMINISTERED. THE PATIENT HAD NO SEQUELAE. THIS PATIENT WAS PREVIOUSLY REPORTED WITH LIMITED INFORMATION FROM AN OLDER RELATED ARTICLE UNDER MANUFACTURER REPORT # 2182207-2008-06650 (2008). THE SOURCE OF THE PREVIOUS ARTICLE IS LISTED BELOW. PLEASE DISREGARD THAT REPORT AND CONSIDER THIS THE ACTIVE REPORT. ANY ADDITIONAL INFORMATION RECEIVED WILL BE FILED UNDER THIS REPORT. PREVIOUS ARTICLE: KHERA J, GHOSH D, LUCIANO M. A STUDY OF INTRATHECAL BACLOFEN PUMPS IN CHILDREN: EXPERIENCE FROM A TERTIARY CARE CENTER. NEUROLOGY. 2008;70(11, SUPPL.1):A131. TO DETERMINE INDICATIONS, UTILITY, AND COMPLICATIONS OF INTRATHECAL BACLOFEN (ITB) PUMP THERAPY IN CHILDREN. SINGLE CENTER, RETROSPECTIVE REVIEW AFTER IRB APPROVAL. INCLUSION CRITERIA: PATIENTS <(><<)> 21 YEARS WITH ITB PUMP PLACED BETWEEN 1996-2006. MASTER FILE: 0700597953.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 252624 | UNKNOWN_PUMP | PUMP, INFUSION, IMPLANTED, PROGRAMMABLE | LKK | MEDTRONIC NEUROMODULATION | UNKNOWN_PUMP |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 00006 YR | Required Intervention |